Bigul

Medico Intercontinental Ltd - 539938 - Statement On Deviation Or Variation Of Funds Raised Though Preferential Issue Of Equity Shares.

Statement of Deviation & Variation - No Deviation or Variation in the utilization proceeds of the preferential issue of Equity Shares for the quarter ended September 30, 2023.
08-11-2023
Bigul

Medico Intercontinental Ltd - 539938 - Results - Quarter Ended 30 September 2023

Financial Results for the Quarter ended 30 September 2023.
08-11-2023
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30, 33 And 42 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 08, 2023, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on September 30, 2023 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, Statement of Assets and Liabilities and Cash Flow Statement along with Limited Review Report' for the quarter ended on September 30, 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 03:30 PM and concluded at 04:40 PM.
08-11-2023
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve The unaudited Financial Results (Standalone and Consolidated), Statement of Assets and Liabilities and Cash Flow Statement for quarter and half year ended 30th September, 2023 and any other business items as per agenda circulated.
31-10-2023
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2023.
09-10-2023
Bigul

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

Intimation of Closure of trading window for the quarter and half year ended 30th September, 2023.
30-09-2023
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication of unaudited financial results for the quarter ended 30 June 2023.
16-08-2023
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Utilization For The Quarter Ended 30 June 2023

Pursuant to Reg 32 of the SEBI (LODR) Regulations, 2015, as amended read with SEBI circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that during the quarter ended 30 June 2023, there was no deviation or variation in the utilization of proceeds of the preferential issue of equity shares from the objects as stated in the PAS-4.
14-08-2023
Bigul

Medico Intercontinental Ltd - 539938 - Results - Quarter Ended 30/06/2023

Results for the quarter ended 30th June, 2023.
14-08-2023
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Board Meeting And Compliances Of Regulation 30, 33 And 42 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., August 14, 2023, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30, 2023 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results along with Limited Review Report' for the quarter ended on June 30, 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:35 PM.
14-08-2023
Next Page
Close

Let's Open Free Demat Account